Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
By E. Diamanti-Kandarakis, A. Dunaif. Endocrine reviews, 2012
1,734 citations recorded by the source corpus.
Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/b2b7fa060bf61f261edf17bef51cbbbd222742e0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Sarra Setrerrahmane
- Wenwei Xie
- Ying Wang
- M. Banday
- A. Sameer
- Hanmei Xu
- S. Nissar
- Xiaowei Chi
Citations in the corpus
- Pathophysiology of diabetes: An overview (2020, background): “This syndrome is associated with menstruation disorders (primary amenorrhea or oligomenorrhea) and specific forms of polycystic ovarian syndrome characterized by hirsutism due to hyperandrogenism and multiple enlarged cysts on the ovaries, in females[98]; also, acanthosis nigricans, a skin pigmentat”
- Trends in insulin resistance: insights into mechanisms and therapeutic strategy (2022, background): “Specifically, IR leads to compensatory hyperinsulinemia, which stimulates GnRH gene transcription through MAPK pathway in PCOS and increases LH pulse secretion, thereby significantly increasing ovarian androgen synthesis.(12,332) In addition to directly interfering with insulin signaling, androgens ”